MELISSA
Mobile Artificial Intelligence Solution for Diabetes Adapted Care
- Description
The MELISSA project, a collaboration of 12 partners from seven countries, aims to provide a clinically validated, effective, trustworthy, and cost-efficient artificial intelligence (AI)-based digital diabetes management solution to support both health care providers (HCPs) and insulin-treated patients with diabetes (PwD) in their daily routine with personalised treatment and care recommendations.
- Coordinator
- Programme
- Horizon Europe & sub-programmes
- Duration
- 48 months (June 2022 - May 2026)
- Project funding
- € 7,786,709.00
- Project partners
- 12
- Project website
- https://melissa-diabetes.eu/
